Leflunomide EP Impurity G

Isolation and characterization of a degradation product in leflunomide and a validated selective stability-indicating HPLC–UV method for their quantification
Balraj Saini and Gulshan Bansal
J Pharm Anal. 2015 Jun; 5(3): 207–212.
 
Rapid Stability Indicating HPLC Method for the Analysis of Leflunomide and Its Related Impurities in Bulk Drug and Formulations
Useni Reddy Mallu,1 Venkateswara Rao Anna,1 and Bikshal Babu Kasimala
Turk J Pharm Sci. 2019 Dec; 16(4): 457–465.

Leflunomide EP Impurity G is chemically 5-Methyl-N-(p-tolyl)isoxazole-4-carboxamide. Leflunomide EP Impurity G is supplied with detailed characterization data compliant with regulatory guideline. Leflunomide EP Impurity G can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Leflunomide.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.